4.3 Article

Plasma levels of MMP-2, MMP-9 and TIMP-1 are not associated with arterial stiffness in subjects with type 2 diabetes mellitus

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jdiacomp.2008.10.004

关键词

MMP-2; MMP-9; TIMP-1; Aortic distensibility; Augmentation index; Type 2 diabetes mellitus

资金

  1. European Union [03E/95]
  2. General Secretariat for Research and Technology, Greece
  3. National and Kapodistrian University of Athens, Greece

向作者/读者索取更多资源

Objective: Increased arterial stiffness is a marker of atherosclerosis and is recognised early in the course of type 2 diabetes mellitus (T2DM). Matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) are a family of proteolytic enzymes which are essential for the structure and function of large arteries. In this study, we examined for relationships between MMP and TIMP-1 and indices of arterial stiffness in subjects with T2DM. Research Design and Methods: A total of 60 subjects with T2DM and 60 nondiabetic subjects were recruited. Aortic distensibility (AD) was assessed noninvasively by ultrasonography and augmentation index by pulse wave analysis. Results: The values of AD were lower in subjects with T2DM than in controls (P<.001), while those of augmentation index were not significantly different between the two groups. Plasma concentrations of MMP-2 and MMP-9 were not different between diabetic and nondiabetic participants, while those of TIMP-I were lower in the diabetic patients (P=.005). In the diabetes group, no significant associations were found between either AD or augmentation index and MMPs as well as TIMP-1, while duration of diabetes emerged as the strongest predictor of AD (P<.001). In the nondiabetic group, nonsignificant associations were also found between AD or augmentation index and MMPs as well as TIMP-1. Conclusion: In patients with T2DM, plasma levels of MMP and TIMP-1 are not associated with arterial stiffness assessed by either AD or augmentation index. (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

The Effect of Oxidative Stress and Antioxidant Therapies on Pancreatic β-cell Dysfunction: Results from in Vitro and in Vivo Studies

Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Chrysi Koliaki, Ourania A. Kosta, Nikolaos Tentolouris

Summary: Oxidative stress is implicated in many diseases, particularly in pancreatic beta-cell dysfunction and apoptosis associated with diabetes. Antioxidants, especially natural extracts, have shown protective effects on pancreatic beta-cells in vitro and in vivo, while evidence for the antioxidant effects of antidiabetic drugs is limited.

CURRENT MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

The Use of L-Glucose in Cancer Diagnosis: Results from In Vitro and In Vivo Studies

Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Iordanis Mourouzis, Constantinos Pantos, Nikolaos Tentolouris

Summary: This mini-review presents current literature data on the role of L-glucose in cancer diagnosis, highlighting the specific uptake of L-glucose fluorescent probes by malignant cancer cells. Limited studies have examined the ability of cancer cells to take up L-glucose, suggesting the potential use of L-glucose fluorescent probes for visualization and characterization of cancer cells. Further research on the biological effects of L-glucose in cancer is warranted.

CURRENT MEDICINAL CHEMISTRY (2021)

Article Endocrinology & Metabolism

Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis

Marianne Benn, Frida Emanuelsson, Anne Tybjaerg-Hansen, Borge G. Nordestgaard

Summary: The study found a causal relationship between high plasma glucose levels and increased risk of ischemic stroke. Glucose-lowering drugs such as glucagon-like peptide-1 receptor agonists and thiazolidinediones were shown to reduce the risk of stroke. These results may help guide clinicians in treating individuals at high risk for ischemic stroke.

DIABETOLOGIA (2021)

Review Endocrinology & Metabolism

The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression

Nikolaos Tentolouris, Georgia Samakidou, Ioanna Eleftheriadou, Anastasios Tentolouris, Edward B. Jude

Summary: This meta-analysis suggests that vitamin D supplementation is beneficial for ICU admission in COVID-19 patients, but not for mortality. Further research is needed to understand the benefits of vitamin D in COVID-19.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)

Article Nutrition & Dietetics

Effect of Long-Term Hydroxytyrosol Administration on Body Weight, Fat Mass and Urine Metabolomics: A Randomized Double-Blind Prospective Human Study

Christina Fytili, Theodora Nikou, Nikolaos Tentolouris, Ioulia K. Tseti, Charilaos Dimosthenopoulos, Petros P. Sfikakis, Dimitrios Simos, Alexandros Kokkinos, Alexios L. Skaltsounis, Nikolaos Katsilambros, Maria Halabalaki

Summary: This study aimed to investigate the potential effect of Hydroxytyrosol (HT) on human obesity. The results showed significant weight and visceral fat mass loss after 4 weeks of intervention in the group receiving the maximum HT dosage. This is the first study using a human cohort for a prolonged period of obesity research.

NUTRIENTS (2022)

Article Immunology

Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study

Eleni Papadokostaki, Anastasios Tentolouris, Ioanna A. Anastasiou, Mina Psichogiou, Evangelia Iliaki, Ioanna Eleftheriadou, Angelos Hatzakis, Nikolaos Tentolouris

Summary: The mRNA-based BNT162b2 vaccine showed high efficacy against severe SARS-CoV-2 infection. Limited data is available regarding the immune response in people with diabetes after vaccination with the BNT162b2 vaccine. This study found that almost 17% of participants with diabetes did not develop adequate immune response after the first dose, but the response became high and similar between participants with and without diabetes after the second dose, and remained stable even two months after the second dose. There was no significant difference in antibody levels between participants with and without diabetes throughout the study. At least two doses of the BNT162b2 vaccine are required for sufficient and sustainable immune response in people with diabetes.

VACCINES (2022)

Article Biochemistry & Molecular Biology

Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)

Maroula G. Kokotou, Christiana Mantzourani, Charikleia S. Batsika, Olga G. Mountanea, Ioanna Eleftheriadou, Ourania Kosta, Nikolaos Tentolouris, George Kokotos

Summary: This study presents a fast and straightforward liquid chromatography-high resolution mass spectrometry method for the simultaneous determination of 74 free fatty acids (FFAs) in human plasma. The method avoids derivatization steps and tedious sample preparation, making it suitable for the diagnosis and monitoring of metabolic disorders.

BIOMEDICINES (2022)

Letter Cardiac & Cardiovascular Systems

Acute effect of coffee consumption on blood pressure, QTc interval, and heart rate variability in people with type 2 diabetes

Ourania Zacharopoulou, Georgia Samakidou, Ioanna Eleftheriadou, Anastasios Tentolouris, Nikolaos Chatzieleftheriou, Ourania Kosta, Nikolaos Tentolouris

HELLENIC JOURNAL OF CARDIOLOGY (2022)

Article Nutrition & Dietetics

Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity*

Nikolaos Perakakis, Alexander Kokkinos, Angeliki M. Angelidi, Dimitrios Tsilingiris, Anna Gavrieli, Maria Yannakoulia, Nicholas Tentolouris, Christos S. Mantzoros

Summary: This study investigates the concentration changes of PGDPs after oral or intravenous intake of different nutrients and finds that their levels are regulated by body weight, administration route, and nutrient type. Obese individuals have increased levels of PGDPs before and after meals, which remain elevated after a mixed meal test.

CLINICAL NUTRITION (2022)

Review Environmental Sciences

The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus

Stamatina Driva, Aliki Korkontzelou, Serena Tonstad, Nikolaos Tentolouris, Paraskevi Katsaounou

Summary: Smokers with diabetes mellitus can substantially lower their risks of microvascular and macrovascular diabetic complications, particularly cardiovascular disease, by quitting smoking. However, post-smoking-cessation weight gain may negate some of the benefits of quitting smoking and discourage further attempts to quit. Weight gain can transiently exacerbate diabetes and worsen glycemic control and metabolic profile.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Review Biochemistry & Molecular Biology

The Beneficial Effects of Bariatric-Surgery-Induced Weight Loss on Renal Function

Diego Moriconi, Monica Nannipieri, Prince Dadson, Javier Rosada, Nikolaos Tentolouris, Eleni Rebelos

Summary: Obesity is an independent risk factor for chronic kidney disease, but weight loss induced by bariatric surgery can improve obesity-related glomerulopathy and renal function. However, assessing the impact of obesity and weight loss on renal function is challenging.

METABOLITES (2022)

Article Ophthalmology

Associations of Alzheimer Disease-Protective APOE Variants With Age-Related Macular Degeneration

Katrine L. L. Rasmussen, Anne Tybjaerg-Hansen, Borge G. Nordestgaard, Ruth Frikke-Schmidt

Summary: This study aims to determine the association between genetic variations in the apolipoprotein E (APOE) gene and the risk of age-related macular degeneration (AMD). The results suggest that structural variations in the APOE gene may be important for the risk of AMD in individuals of European ancestry.

JAMA OPHTHALMOLOGY (2023)

Article Endocrinology & Metabolism

Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis

Gian Paolo Fadini, Cristobal Morales, Irene Caballero, Beatriz Gonzalez, Nikolaos Tentolouris, Agostino Consoli

Summary: This study extends a previous analysis of real-world data in patients with type 2 diabetes initiating dapagliflozin in Italy, Greece, and Spain. The results confirm the efficacy of dapagliflozin in reducing HbA1c in diverse real-world settings, with similar effects across countries and baseline characteristics.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)

Article Nutrition & Dietetics

Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals

Konstantinos Stefanakis, Alexander Kokkinos, Stamatia Simati, Georgia Argyrakopoulou, Sofia K. Konstantinidou, Matina Kouvari, Ajay Kumar, Bhanu Kalra, Christos S. Mantzoros

Summary: This study measured the levels of all proglucagon-derived peptides (PGDPs) in response to three mixed meal tolerance tests (MMTs), comparing postprandial PGDP responses between lean and obese subjects and between high-fat and high-carbohydrate meals. The results showed that the fat and carbohydrate content of a meal can significantly affect the postprandial levels of PGDPs, and the presence of leanness or obesity also influences the circulating levels of select PGDPs.

CLINICAL NUTRITION (2023)

Article Public, Environmental & Occupational Health

Vitamin D prescribing practices among clinical practitioners during the COVID-19 pandemic

Edward B. Jude, Nikolaos Tentolouris, Ashu Rastogi, Moi H. Yap, Hermelinda C. Pedrosa, Stephanie F. Ling

Summary: This survey has shown that many clinicians prescribe vitamin D for the prevention and treatment of COVID-19, especially in Asia. Most doctors also recommend measuring vitamin D levels, but it is not common in patients with COVID-19.

HEALTH SCIENCE REPORTS (2022)

暂无数据